Septerna (SEPN) Total Current Liabilities (2023 - 2026)
Septerna (SEPN) posted quarterly Total Current Liabilities of $78.2 million for Q1 2026, up 634.77% year-over-year from $10.6 million in Q1 2025, and down 10.08% quarter-over-quarter from $86.9 million in Q4 2025.
Septerna (SEPN) Total Current Liabilities (2023 - 2026) Analysis & Trends
Septerna's Total Current Liabilities history runs 4 years deep, the most recent figure standing at $78.2 million for Q1 2026.
- In Q1 2026, Total Current Liabilities rose 634.77% year-over-year to $78.2 million; the TTM figure through Mar 2026 stood at $78.2 million (up 634.77% YoY), while the FY2025 annual figure was $86.9 million, up 576.56% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $78.2 million, down from $86.9 million in the prior quarter.
- The five-year high for Total Current Liabilities was $86.9 million in Q4 2025, with the low at $6.9 million in Q4 2023.
- The 4-year median for Total Current Liabilities is $14.2 million (2024), against an average of $37.4 million.
- The sharpest annual moves came in 2024 and 2026: Total Current Liabilities surged 85.84% in 2024, then soared 634.77% in 2026.
- Septerna's Total Current Liabilities stood at $6.9 million in 2023, then soared by 85.84% to $12.8 million in 2024, then surged by 576.56% to $86.9 million in 2025, then declined by 10.08% to $78.2 million in 2026.
- Business Quant data shows SEPN's Total Current Liabilities at $78.2 million in Q1 2026, $86.9 million in Q4 2025, and $75.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Septerna | 2.08 Bn | 2.08 Bn | - | 79.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 79.32 Mn |
| Mar 31, 2026 | 78.17 Mn |
| Dec 31, 2025 | 86.93 Mn |
| Sep 30, 2025 | 75.28 Mn |
| Jun 30, 2025 | 15.13 Mn |
| Mar 31, 2025 | 10.64 Mn |
| Dec 31, 2024 | 12.85 Mn |
| Sep 30, 2024 | 13.23 Mn |
| Dec 31, 2023 | 6.91 Mn |